ACET Q4 2017 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$431M-442.9% YoY

Gross Profit

-$749M174.0% margin

Operating Income

-$68M15.8% margin

Net Income

-$64M14.9% margin

EPS (Diluted)

$-36.64

QoQ Revenue Growth

-Infinity%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

-$5M

Balance Sheet

Total Assets

$55M

Total Liabilities

$6M

Stockholders' Equity

-$32M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$431M	$126M	-442.9%
Gross Profit	-$749M	$31M	-2531.6%
Operating Income	-$68M	$1M	-4992.0%
Net Income	-$64M	-$564,000	-11275.7%

Revenue Segments

Human Health

$103M60%

Performance Chemicals

$34M20%

Pharmaceutical Ingredients

$34M20%